Application 018868
- Type
- NDA
- Sponsor
- KALAPHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 20MG | No | No |
| 002 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018868-001 | FUROSEMIDE | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | ||
| N018868-002 | FUROSEMIDE | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSEMIDE | FUROSEMIDE | Hospira, Inc. | aaced7a8-c3d7-4d66-8c07-aa407b8b3f35 | 2026-05-13 | Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650 | 2026-05-06 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals, Inc. | a23fc1e0-2d16-43a8-a34e-f6505dcd6316 | 2026-04-29 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals Inc. | cad102d7-0197-4cff-bb80-9f0b5bcb599b | 2026-04-29 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 7181e528-c862-4dd7-8446-9011e4c7312a | 2026-04-23 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Redpharm Drug | 37457273-38a1-f938-e063-6294a90a50ab | 2026-04-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Coupler LLC | 4cc2c2d1-2fa4-f6b6-e063-6294a90a290e | 2026-03-11 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Direct_Rx | e9be5c3b-4b18-7ad2-e053-2995a90a4a8b | 2026-03-09 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Marlex Pharmaceuticals, Inc. | 4bd1b15e-354e-051f-e063-6294a90a3f3b | 2026-03-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | bd45c963-a413-e9a1-e053-2a95a90a1438 | 2026-02-19 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals Inc. | adda78ee-0cf5-4613-a748-5d6571afe354 | 2026-01-19 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Cardinal Health 107, LLC | 2590ebb6-ce2a-4e23-9244-e54e3010d488 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | AvKARE | d4c532be-1f3f-60d3-e053-2995a90a98be | 2026-01-14 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Meitheal Pharmaceuticals Inc. | a2e3c748-28ce-4c50-a182-721912919840 | 2026-01-14 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 8f56d6f6-a5ea-4171-9e24-d2fdb11a65f8 | 2026-01-13 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Micro Labs Limited | 2f547f7c-0322-465c-9764-43f955d98ab2 | 2026-01-11 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Phlow Corporation | 08a44bdd-028d-41af-9d4e-70971b0bcc4e | 2026-01-09 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | 13ba97a7-598a-76a4-e063-6294a90a45c5 | 2026-01-02 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Northwind Health Company, LLC | 1d99e151-75ba-6a75-e063-6294a90a4360 | 2026-01-01 | Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.